Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Farid Boulad; Guenther Koehne; Nancy A. Kernan; Susan E. Prockop; Trudy N. Small; Andromachi Scaradavou; Miguel-Angel Perales; Hugo R Castro-Malaspina; Esperanza B. Papadopoulos; Jenna D Goldberg; Elizabeth G Klein; Rachel Kobos; Ann A. Jakubowski; Doris Ponce; Juliet Barker; James W. Young; Craig S. Sauter; Sergio Giralt; Richard J. O'Reilly

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Farid Boulad, Guenther Koehne, Nancy A. Kernan, Susan E. Prockop, Trudy N. Small, Andromachi Scaradavou, Miguel-Angel Perales, Hugo R Castro-Malaspina, Esperanza B. Papadopoulos, Jenna D Goldberg, Elizabeth G Klein, Rachel Kobos, Ann A. Jakubowski, Doris Ponce, Juliet Barker, James W. Young, Craig S. Sauter, Sergio Giralt, Richard J. O'Reilly

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 16 2012
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

Boulad, F., Koehne, G., Kernan, N. A., Prockop, S. E., Small, T. N., Scaradavou, A., Perales, M.-A., Castro-Malaspina, H. R., Papadopoulos, E. B., Goldberg, J. D., Klein, E. G., Kobos, R., Jakubowski, A. A., Ponce, D., Barker, J., Young, J. W., Sauter, C. S., Giralt, S., & O'Reilly, R. J. (2012). Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.. Blood.

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies. / Boulad, Farid; Koehne, Guenther; Kernan, Nancy A. et al.
2012. Blood.

Research output: Contribution to conference › Presentation

Boulad, F, Koehne, G, Kernan, NA, Prockop, SE, Small, TN, Scaradavou, A, Perales, M-A, Castro-Malaspina, HR, Papadopoulos, EB, Goldberg, JD, Klein, EG, Kobos, R, Jakubowski, AA, Ponce, D, Barker, J, Young, JW, Sauter, CS, Giralt, S & O'Reilly, RJ 2012, 'Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.', Blood, 1/1/20.

@conference{9adeb1eb494048849e7d3bb7617a7743,

title = "Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.",

author = "Farid Boulad and Guenther Koehne and Kernan, \{Nancy A.\} and Prockop, \{Susan E.\} and Small, \{Trudy N.\} and Andromachi Scaradavou and Miguel-Angel Perales and Castro-Malaspina, \{Hugo R\} and Papadopoulos, \{Esperanza B.\} and Goldberg, \{Jenna D\} and Klein, \{Elizabeth G\} and Rachel Kobos and Jakubowski, \{Ann A.\} and Doris Ponce and Juliet Barker and Young, \{James W.\} and Sauter, \{Craig S.\} and Sergio Giralt and O'Reilly, \{Richard J.\}",

note = "Abstract 3144 Based on encouraging results with the use of clofarabine (CLO) for reinduction treatment of acute leukemias, we have developed two allograft protocols for patients with hematologic malignancies with a cytoreductive regimen, using CLO in combination with melphalan (Mel) and thiotepa (Thio).; Blood ; Conference date: 01-01-2020",

year = "2012",

month = nov,

day = "16",

language = "American English",

}

TY - CONF

T1 - Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

AU - Boulad, Farid

AU - Koehne, Guenther

AU - Kernan, Nancy A.

AU - Prockop, Susan E.

AU - Small, Trudy N.

AU - Scaradavou, Andromachi

AU - Perales, Miguel-Angel

AU - Castro-Malaspina, Hugo R

AU - Papadopoulos, Esperanza B.

AU - Goldberg, Jenna D

AU - Klein, Elizabeth G

AU - Kobos, Rachel

AU - Jakubowski, Ann A.

AU - Ponce, Doris

AU - Barker, Juliet

AU - Young, James W.

AU - Sauter, Craig S.

AU - Giralt, Sergio

AU - O'Reilly, Richard J.

N1 - Abstract 3144 Based on encouraging results with the use of clofarabine (CLO) for reinduction treatment of acute leukemias, we have developed two allograft protocols for patients with hematologic malignancies with a cytoreductive regimen, using CLO in combination with melphalan (Mel) and thiotepa (Thio).

PY - 2012/11/16

Y1 - 2012/11/16

UR - http://www.bloodjournal.org/content/120/21/3144/tab-article-info?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Conference

Disciplines

Other files and links

Cite this